Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Milestone Pharmaceuticals Inc. (MIST)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 32.6 | 74.0 | | 37.3 | 63.2 | 92.2 | 114.1 | 111.4 |
| Short-term investments | 55.0 | 27.0 | | 39.9 | 23.0 | 8.0 | | 15.0 |
| Other current assets | 7.0 | 7.6 | | 5.7 | 4.3 | 4.7 | 4.8 | 6.3 |
| Total current assets | 94.6 | 108.5 | | 82.9 | 90.5 | 105.0 | 118.9 | 132.8 |
| Property, plant, and equipment, net | 0.3 | 0.3 | | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total assets | 97.0 | 111.1 | | 85.8 | 91.3 | 105.8 | 119.8 | 133.8 |
| |
| Accounts payable | 2.4 | 2.9 | | 2.9 | 1.5 | 3.1 | 4.4 | 4.2 |
| Accrued expenses | 1.9 | 1.1 | | 1.9 | 0.5 | 0.5 | 1.5 | 1.0 |
| Short-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 2.5 | 4.0 | | 1.8 | 2.2 | 1.0 | 0.9 | 0.6 |
| Total current liabilities | 6.8 | 8.0 | | 6.5 | 4.3 | 4.6 | 6.8 | 5.8 |
| Long-term debt | 48.1 | 47.3 | | | | | | |
| Other liabilities | 1.7 | 1.9 | | 2.1 | 0.4 | 0.4 | 0.5 | 0.5 |
| Total liabilities | 56.6 | 57.1 | | 8.6 | 4.6 | 5.0 | 7.2 | 6.4 |
| |
| Shareholders' equity [+] | 40.4 | 53.9 | | 77.2 | 86.7 | 100.8 | 112.6 | 127.4 |
| Paid-in capital | 29.1 | 26.6 | | 22.4 | 20.1 | 17.8 | 15.7 | 13.8 |
| Retained earnings | -297.3 | -281.3 | | -251.5 | -237.0 | -220.3 | -206.3 | -189.4 |
| Tangible shareholders' equity | 40.4 | 53.9 | | 77.2 | 86.7 | 100.8 | 112.6 | 127.4 |
|